Increasing risk of breakthrough COVID-19 in outbreaks with high attack rates in European long-term care facilities, July to October 2021

被引：16

作者：

Suetens, Carl ^{[1
]}

Kinross, Pete ^{[1
]}

Gallego Berciano, Pilar ^{[2
]}

Arroyo Nebreda, Virginia ^{[2
]}

Hassan, Eline ^{[3
]}

Calba, Clementine ^{[4
]}

Fernandes, Eugenia ^{[5
]}

Peralta-Santos, Andre ^{[5
]}

Casaca, Pedro ^{[5
]}

Shodu, Nathalie ^{[6
]}

Dequeker, Sara ^{[6
]}

Kontopidou, Flora ^{[7
]}

Pappa, Lamprini ^{[7
]}

Kacelnik, Oliver ^{[8
]}

Borseth, Anita Wang ^{[8
]}

O'Connor, Lois ^{[9
]}

Garvey, Patricia ^{[9
]}

Liausediene, Rasa ^{[10
]}

Valinteliene, Rolanda ^{[11
]}

Ernst, Corinna ^{[12
]}

Mossong, Joel ^{[12
]}

Stefkovicova, Maria ^{[13
,14
]}

Prostinakova, Zuzana ^{[13
]}

Danielsen, Ann Caroline ^{[1
]}

Mougkou, Aikaterini ^{[1
]}

Lamb, Favelle ^{[1
]}

Cenciarelli, Orlando ^{[1
]}

Monnet, Dominique L. ^{[1
]}

Plachouras, Diamantis ^{[1
]}

机构：

[1] European Ctr Dis Prevent & Control ECDC, Stockholm, Sweden

[2] Inst Hlth Carlos III, Madrid, Spain

[3] Sante Publ France, St Maurice, France

[4] Sante Publ France, Reg Unit Provence Alps French Riviera & Corsica, Marseille, France

[5] Directorate Gen Hlth, Lisbon, Portugal

[6] Sciensano, Brussels, Belgium

[7] Directorate Epidemiol Surveillance & Intervent In, Athens, Greece

[8] Norwegian Inst Publ Hlth, Oslo, Norway

[9] Hlth Protect Surveillance Ctr, Dublin, Ireland

[10] Natl Publ Hlth Ctr Minist Hlth, Vilnius, Lithuania

[11] Publ Hlth Technol Ctr, Inst Hyg, Vilnius, Lithuania

[12] Hlth Directorate, Luxembourg, Luxembourg

[13] Reg Publ Hlth Author, Trencin, Slovakia

[14] Alexander Dubcek Univ, Trencin, Slovakia

来源：

EUROSURVEILLANCE | 2021年 / 26卷 / 49期

关键词：

COVID-19; vaccine;

D O I：

10.2807/1560-7917.ES.2021.26.49.2101070

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

We collected data from 10 EU/EEA countries on 240 COVID-19 outbreaks occurring from July-October 2021 in long-term care facilities with high vaccination coverage. Among 17,268 residents, 3,832 (22.2%) COVID19 cases were reported. Median attack rate was 18.9% (country range: 2.8-52.4%), 17.4% of cases were hospitalised, 10.2% died. In fully vaccinated residents, adjusted relative risk for COVID-19 increased with outbreak attack rate. Findings highlight the importance of early outbreak detection and rapid containment through effective infection prevention and control measures.

引用

页数：6

共 10 条

[1] Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel
Bar-On, Yinon M.
Goldberg, Yair
Mandel, Micha
Bodenheimer, Omri
Freedman, Laurence
Kalkstein, Nir
Mizrahi, Barak
Alroy-Preis, Sharon
Ash, Nachman
Milo, Ron
Huppert, Amit
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (15) : 1393 - 1400
[2] Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
Bernal, Jamie Lopez
Andrews, Nick
Gower, Charlotte
Gallagher, Eileen
Simmons, Ruth
Thelwall, Simon
Stowe, Julia
Tessier, Elise
Groves, Natalie
Dabrera, Gavin
Myers, Richard
Campbell, Colin N. J.
Amirthalingam, Gayatri
Edmunds, Matt
Zambon, Maria
Brown, Kevin E.
Hopkins, Susan
Chand, Meera
Ramsay, Mary
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (07) : 585 - 594
[3] ECDC, 2022, Overview of the implementation of COVID-19 vaccination strategies and vaccine deployment plans in the EU/EEA
[4] ECDC, 2020, CAS DEF COR DIS 2019
[5] European Centre for Disease prevention and Control (ECDC), 2021, DAT COLL COVID 19 OU
[6] European Centre for Disease Prevention and Control Rapid Risk Assessment, 2021, COVID 19 OUTBR LONG
[7] SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3
Falsey, Ann R.
Frenck, Robert W., Jr.
Walsh, Edward E.
Kitchin, Nicholas
Absalon, Judith
Gurtman, Alejandra
Lockhart, Stephen
Bailey, Ruth
Swanson, Kena A.
Xu, Xia
Koury, Kenneth
Kalina, Warren
Cooper, David
Zou, Jing
Xie, Xuping
Xia, Hongjie
Tuereci, Ozlem
Lagkadinou, Eleni
Tompkins, Kristin R.
Shi, Pei-Yong
Jansen, Kathrin U.
Sahin, Ugur
Dormitzer, Philip R.
Gruber, William C.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (17) : 1627 - 1629
[8] Force of infection: a determinant of vaccine efficacy?
Kaslow, David C.
[J]. NPJ VACCINES, 2021, 6 (01)
[9] Nanduri S, 2021, MMWR-MORBID MORTAL W, V70, P1163, DOI 10.15585/mmwr.mm7034e3
[10] O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI [10.1086/344188, 10.1086/502007]

← 1 →